KIAA1191

Chr 5

KIAA1191

Also known as: p33MONOX, p60MONOX

The protein is a mitochondrial NADPH-dependent oxidoreductase that may regulate neuronal survival, differentiation and axonal outgrowth. This gene is extremely intolerant to loss-of-function variants (pLI near 1.0), suggesting mutations would cause severe developmental disorders, though specific associated phenotypes have not yet been established. The inheritance pattern for pathogenic variants would be autosomal recessive or dominant depending on the specific mutation.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
2
Pubs (1 yr)
46
P/LP submissions
0%
P/LP missense
1.05
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryKIAA1191
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
45 unique Pathogenic / Likely Pathogenic· 52 VUS of 110 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.05LOEUF
pLI 0.000
Z-score 1.40
OE 0.65 (0.411.05)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.91Z-score
OE missense 0.81 (0.700.93)
145 obs / 179.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.65 (0.411.05)
00.351.4
Missense OE0.81 (0.700.93)
00.61.4
Synonymous OE0.93
01.21.6
LoF obs/exp: 12 / 18.5Missense obs/exp: 145 / 179.5Syn Z: 0.45
DN
0.7327th %ile
GOF
0.73top 25%
LOF
0.3939th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

110 submitted variants in ClinVar

Classification Summary

Pathogenic45
VUS52
Likely Benign6
45
Pathogenic
52
VUS
6
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
45
0
45
Likely Pathogenic
0
0
0
0
0
VUS
0
46
6
0
52
Likely Benign
0
3
2
1
6
Benign
0
0
0
0
0
Total049531103

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

KIAA1191 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 1 results · since 2015Search PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found